Phenyltoloxamine PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Acts as an inverse agonist at histamine H1 receptors, reducing histamine-mediated itching, vasodilation and capillary permeability. It crosses the blood-brain barrier and may cause sedation.
Indications / reported uses
Relief of allergic symptoms such as pruritus, allergic rhinitis and urticaria, usually in combination products where authorised.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Phenyltoloxamine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Phenyltoloxamine Permitted Daily Exposure (PDE) report (the Phenyltoloxamine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Phenyltoloxamine Occupational Exposure Limit (OEL) report (the Phenyltoloxamine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.